ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

Simmons Cancer Center at UT Southwestern Wins NCI Comprehensive Designation and $7.5 Million.

September 10, 2010

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

ACOS Studies Show Shift To Less Surgery In Breast Cancer

December 15, 1978

50-Gene Set Identifies Known Types Of Breast Cancer

February 27, 2009

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997